News & Media

This EOM Pharmaceuticals website may contain information, news, and/or press releases, the content of which is accurate or current only as of the date of the particular information, news, press release, or posting. EOM does not update press releases once they have been made public.

Media Kit

News Highlights

EOM PHARMACEUTICALS ANNOUNCES ITS PRE-IND MEETING REQUEST WITH U.S. FDA TO EVALUATE PLANS FOR A PHASE 2 CLINICAL TRIAL OF ITS INVESTIGATIONAL DUAL-ACTING, BROAD-SPECTRUM IMMUNOMODULATOR IN COVID-19 PATIENTS

December 24, 2020

MONTVALE, N.J. – December 23, 2020 — EOM Pharmaceuticals, Inc., a privately held, clinical-stage company, today announced it has filed a pre-Investigational New Drug Application (pre-IND) meeting request and complete pre-IND briefing documents with the U.S. Food and Drug Administration (FDA) to discuss the company’s plans to evaluate the safety and efficacy of its dual-acting, […]

READ MORE »

EOM PHARMACEUTICALS APPOINTS BUSINESS VETERAN WAYNE I. DANSON AS CHIEF FINANCIAL OFFICER AND TREASURER

December 17, 2020

MONTVALE, NEW JERSEY – December 17, 2020 — EOM Pharmaceuticals, a privately held, clinical-stage company, announced today the appointment of business veteran Wayne I. Danson, CPA, as Chief Financial Officer and Treasurer. Mr. Danson will be responsible for leading the Company’s financial operations including financial planning and analysis, capital markets, investor relations, accounting, tax and […]

READ MORE »

Press Releases

December 24, 2020

EOM PHARMACEUTICALS ANNOUNCES ITS PRE-IND MEETING REQUEST WITH U.S. FDA TO EVALUATE PLANS FOR A PHASE 2 CLINICAL TRIAL OF ITS INVESTIGATIONAL DUAL-ACTING, BROAD-SPECTRUM IMMUNOMODULATOR IN COVID-19 PATIENTS

DOWNLOAD

December 17, 2020

EOM PHARMACEUTICALS APPOINTS BUSINESS VETERAN WAYNE I. DANSON AS CHIEF FINANCIAL OFFICER AND TREASURER

DOWNLOAD